X4 Pharmaceuticals, Inc (XFOR) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.87 | +66.5% |
| 2024 | $-5.59 | +67.3% |
| 2023 | $-17.07 | -1023.0% |
| 2022 | $-1.52 | +61.9% |
| 2021 | $-3.99 | -29.1% |
| 2020 | $-3.09 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.87 | +66.5% |
| 2024 | $-5.59 | +67.3% |
| 2023 | $-17.07 | -1023.0% |
| 2022 | $-1.52 | +61.9% |
| 2021 | $-3.99 | -29.1% |
| 2020 | $-3.09 | — |